Recent News

Agios Initiates Phase 1 Study of AG-348, a First-in-class PKR Activator, for Pyruvate Kinase Deficiency

April 17, 2014
Not Flagship

TransMedics® Announced Final Results of The PROCEED II Heart FDA Pivotal Trial at ISHLT

April 14, 2014
Not Flagship

Receptos Announces Appointment of Mary Lynne Hedley, Ph.D. as Director

April 14, 2014
Not Flagship

Oasys Water Named 2014 Water Technology Company of the Year

April 8, 2014
Not Flagship

Oasys Water Honored as One of Bloomberg’s 2014 New Energy Pioneers at BNEF’s Future of Energy Summit

April 8, 2014
Not Flagship

BIND Therapeutics Presents Clinical Data Highlighting Unique Attributes of Lead Cancer Drug Candidate, BIND-014, at AACR 2014 Annual Meeting

April 7, 2014
Not Flagship

Agios Announces Initial Phase 1 Data Demonstrating Clinical Activity of AG-221, First-in-Class Inhibitor of IDH2 Mutations, in Patients with Advanced Blood Cancers

April 6, 2014
Not Flagship

T2 Biosystems Appoints Michael Pfaller, MD, Chief Medical Officer

April 3, 2014
Not Flagship

BG Medicine, Inc. Announces Proposed Public Offering of Common Stock

April 2, 2014
Not Flagship

Concert Pharmaceuticals Reports Year End 2013 Financial Results

March 31, 2014
Not Flagship

BIND Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results

March 25, 2014
Not Flagship

Seres Health to Present at 21st Annual BioCentury Future Leaders in the Biotech Industry Conference

March 25, 2014
Not Flagship

Acceleron, Celgene and Collaborators Announce Two Publications in Nature Medicine Describing Sotatercept and ACE-536 Therapeutic Potential in Beta-thalassemia and Myelodysplastic Syndromes

March 24, 2014
Not Flagship

Agios Enrolls First Patient in Phase 1 Study of AG-120 in Advanced Solid Tumors with an IDH1 Mutation

March 24, 2014
Not Flagship

BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy

March 20, 2014
Not Flagship

Concert Pharmaceuticals Announces CTP-499 Late Breaking Presentation at the National Kidney Foundation 2014 Spring Clinical Meeting

March 19, 2014
Not Flagship

Agios Announces Enrollment of First Patient in Phase 1 Study of AG-120 in Advanced Hematologic Malignancies with an IDH1 Mutation

March 19, 2014
Not Flagship

Black Duck Appoints Mark Fusco to its Board of Directors

March 18, 2014
Not Flagship

Concert Pharmaceuticals Appoints Wendell Wierenga to Board of Directors

March 14, 2014
Not Flagship

Quanterix’s Simoa Technology to Detect Blood Biomarker for Concussion in Hockey Players

March 14, 2014
Not Flagship

Tangent Medical Appoints Eric Sandberg to Company President

March 13, 2014
Not Flagship

Flagship Ventures Partner David Berry Named a 2014 Young Global Leader by the World Economic Forum

March 11, 2014
Is Flagship Story

BG Medicine Welcomes Inclusion of Galectin-3 in 2014 Indian Consensus Document on Cardiac Biomarkers

March 10, 2014
Not Flagship

Moderna Appoints Biotechnology Investment Banking Veteran Lorence Kim as Chief Financial Officer

March 6, 2014
Not Flagship

Tetraphase Reports Fourth-Quarter and Full-Year 2013 Financial Results

March 6, 2014
Not Flagship

Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

March 6, 2014
Not Flagship

Receptos Reports Fourth Quarter and Year End 2013 Operational and Financial Results

March 5, 2014
Not Flagship

Eleven Biotherapeutics Reports Clinical and Regulatory Updates for EBI-005

March 4, 2014
Not Flagship

Eleven Biotherapeutics Appoints Paul Chaney to Its Board of Directors

March 3, 2014
Not Flagship

BIND Therapeutics Promotes Key Executives: Organization Positioned for Continued Growth

March 3, 2014
Not Flagship

Joule Appoints David Anton Chief Technology Officer

February 28, 2014
Not Flagship

Joule Names Paul Snaith as New President and CEO

February 20, 2014
Not Flagship

Eleven Biotherapeutics Initiates Pivotal Phase 3 Clinical Study with EBI-005 in Dry Eye Disease

February 18, 2014
Not Flagship

Concert Pharmaceuticals Announces Pricing of Initial Public Offering

February 13, 2014
Not Flagship

Pronutria® Announces Launch of Two Clinical Trials

February 13, 2014
Not Flagship

Tangent Medical Receives ISO 13485 Certification

February 12, 2014
Not Flagship

Eleven Biotherapeutics Prices Initial Public Offering

February 6, 2014
Not Flagship

Tetraphase Pharmaceuticals Names Craig Thompson Chief Operating Officer

February 4, 2014
Not Flagship

T2 Biosystems Awarded Top Honor as ‘Most Promising Company’ at Personalized Medicine World Conference 2014

January 30, 2014
Not Flagship

Concert Pharmaceuticals Announces the Appointment of Ryan Daws as Chief Financial Officer

January 23, 2014
Not Flagship

Quanterix Awarded Grant from GE and the NFL’s Head Health Challenge

January 23, 2014
Not Flagship

Renewable Energy Group Enters Industrial Biotech with Acquisition of LS9

January 22, 2014
Not Flagship

Oasys Water Expands to Support Commercialization and Manufacturing of Industry-Pioneering Forward Osmosis Systems

January 15, 2014
Not Flagship

Moderna Launches Onkaido Therapeutics to Focus on the Development of mRNA Therapeutics™ in Oncology with $20 Million Capital Commitment

January 14, 2014
Not Flagship

Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeutics(TM) for Rare Diseases

January 13, 2014
Not Flagship

Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile

January 13, 2014
Not Flagship

T2 Biosystems and Collaborators Announce Discovery of Novel Clot Structure Biology Enabled by T2HemoStat

January 9, 2014
Not Flagship

Selventa Receives Patent for Extracting Knowledge From Biological Networks

January 7, 2014
Not Flagship

Blend Therapeutics Appoints Richard Wooster, Ph.D., as Chief Scientific Officer

January 6, 2014
Not Flagship

Eleven Biotherapeutics Adds Biotech Industry Veterans to Management Team and Board

January 2, 2014
Not Flagship

Eleven Biotherapeutics Files Registration Statement for Proposed Initial Public Offering

January 2, 2014
Not Flagship

Eleven Biotherapeutics Establishes Scientific Advisory Board to Guide Ophthalmic Pipeline and Technology Development

December 23, 2013
Not Flagship

Acceleron Earns $7 Million Milestone Payment for Celgene's Initiation of Sotatercept Phase 2 Clinical Trial in Patients with End Stage Renal Disease on Hemodialysis

December 18, 2013
Not Flagship

Syros Pharmaceuticals Announces Publication of Important Scientific Studies Related to Company's Industry-Leading Gene Control Platform

December 18, 2013
Not Flagship

Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors

December 17, 2013
Not Flagship

Dr. Nathanael Gray, a Syros Pharmaceuticals Scientific Founder, Honored with 2013 Meyenburg Cancer Research Award

December 16, 2013
Not Flagship

Oasys Water Culminates Year with New Partnerships and Sale of World’s Largest, Most Capable Forward Osmosis System

December 12, 2013
Not Flagship

Agios Advances Cancer Metabolism Collaboration with Celgene

December 11, 2013
Not Flagship

Mascoma’s Technology Surpasses One Billion Gallons

December 11, 2013
Not Flagship

T2 Biosystems Strengthens Management Team as Company Prepares for Launch of Flagship T2CandidaTM Diagnostic Test

December 11, 2013
Not Flagship

BG Medicine Welcomes Final Determination by CMS of 2014 Reimbursement for BGM Galectin-3(R) Test

December 10, 2013
Not Flagship

Saudi Aramco Energy Ventures LLC Announces an Equity Investment into Novomer Inc.

December 10, 2013
Not Flagship

Receptos and Ono Pharmaceuticals Expand Collaboration Agreement to Include Transfer of Receptos GPCR Technology Platform

December 10, 2013
Not Flagship

Acceleron and Celgene Report New Interim Clinical Data from Phase 2 Trial of Sotatercept in Beta-Thalassemia at 2013 American Society of Hematology Annual Meeting

December 9, 2013
Not Flagship

Agios Presents Preclinical Data from Lead Programs at American Society of Hematology Annual Meeting

December 9, 2013
Not Flagship

Selecta Biosciences Announces Successful Pre-clinical Study of SEL-201 As An Antigen-Specific Immune Tolerance Treatment for Patients Receiving Factor VIII Therapy

December 9, 2013
Not Flagship

Selecta Biosciences Announces Allowance of the First in a Series of Patents on the Induction of Antigen-Specific Immune Tolerance Using Selecta’s Novel Immunotherapies

December 9, 2013
Not Flagship

Receptos to Initiate Phase 3 Trial of RPC1063 in Relapsing Multiple Sclerosis

December 5, 2013
Not Flagship

Software Industry Veteran Lou Shipley Named CEO of Black Duck Software

December 4, 2013
Not Flagship

Acceleron Pharma Provides Update on Clinical Pipeline at Piper Jaffray Healthcare Conference

December 3, 2013
Not Flagship

Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth

December 2, 2013
Not Flagship

Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT

December 2, 2013
Not Flagship

BIND Therapeutics Co-Founders Demonstrate Ability to Cross Biological Barriers with Targeted Therapeutic Nanoparticles

November 27, 2013
Not Flagship

Avedro Announces FDA Priority Review Status for Corneal Cross-linking New Drug Application

November 25, 2013
Not Flagship

Three VCs Pour $43M Into Editas to “Edit” Out Genetic Disorders

November 25, 2013
Not Flagship

Editas Medicine Created to Discover and Develop Novel Class of Genome Editing Therapeutics

November 25, 2013
Not Flagship

Flagship Takes a Stab at Microbiome Therapy With Seres Health

November 21, 2013
Not Flagship

Flagship VentureLabs™ Introduces Seres Health - Early Leader in the Development of Novel Therapeutics to Treat Diseases of the Human Microbiome

November 21, 2013
Not Flagship

Syros Pharmaceuticals Appoints Stéphane Bancel to Board of Directors

November 21, 2013
Not Flagship

Moderna Therapeutics Announces New Equity Financing, Raising $110M to Develop messenger RNA Therapeutics™

November 20, 2013
Not Flagship

Moderna Vacuums Up Another $110M to Make Messenger RNA Drugs

November 20, 2013
Not Flagship

Independent Multicenter Trial Demonstrates Utility of BGM Galectin-3(R) Test for Accurately Classifying Risk of Unplanned Hospital Readmissions and Adverse Outcomes in Patients With Heart Failure

November 19, 2013
Not Flagship

Avedro and the University of Rostock (Germany) Announce Exclusive Intellectual Property Agreement

November 14, 2013
Not Flagship

BG Medicine, Inc. Appoints Stephen P. Hall as Chief Financial Officer

November 14, 2013
Not Flagship

Tetraphase Reports Third-Quarter 2013 Financial Results

November 14, 2013
Not Flagship

Avedro Announces the Start of Two New US FDA Trials for Accelerated Cross-linking

November 12, 2013
Not Flagship

TransMedics, Inc. Appointed Jeffrey E. Young as Chief Financial Officer

November 8, 2013
Not Flagship

Tetraphase Pharmaceuticals Announces Pricing of Public Offering of Common Stock

November 7, 2013
Not Flagship

Black Duck Maintains Rapid Pace With Record-Breaking Third Quarter

November 7, 2013
Not Flagship

Agios Pharmaceuticals Reports Third Quarter 2013 Financial Results

November 7, 2013
Not Flagship

Mascoma Adds Two Industry Experts to Board of Directors

November 6, 2013
Not Flagship

SilverStaff Clinical Laboratories to Offer BGM Galectin-3(R) Test

November 6, 2013
Not Flagship

BG Medicine Reports 2013 Third Quarter Financial Results

November 6, 2013
Not Flagship

Avedro Announces CE Mark Clearance for its KXL II ™ Advanced Cross-linking System

November 5, 2013
Not Flagship

EcoSense Lighting Closes $15M Financing Round Amidst Rapid Growth

November 5, 2013
Not Flagship

BIND Awarded the RUSNANOPRIZE 2013 for Innovative Development of Nanomedicine

November 4, 2013
Not Flagship

Seventh Sense Biosystems Receives CE Mark Approval for its Touch Activated Phlebotomy Blood Collection and Testing System

November 4, 2013
Not Flagship

Moderna Therapeutics Named to the World Economic Forum's Community of "Global Growth Companies"

October 24, 2013
Not Flagship

Flagship VentureLabs™ Launches Pronutria to Prevent and Treat Diseases with Novel Protein Nutrients

October 22, 2013
Not Flagship

Flagship’s Pronutria Emerges to Make Medicines and Medical Foods

October 22, 2013
Not Flagship

Moderna Therapeutics Announces Expansion to New Headquarters and Laboratories at 200 Tech Square

October 17, 2013
Not Flagship

T2 Biosystems Announces Publication of Data Demonstrating T2Candida® Identifies Candida Significantly Faster than Current Methods

October 17, 2013
Not Flagship

TARIS Biomedical® Enters Research Collaboration with AstraZeneca for Improved Bladder Cancer Treatments

October 16, 2013
Not Flagship

Quanterix Announces Key Patents Issued for Simoa Platform

October 16, 2013
Not Flagship

DARPA Awards Moderna Therapeutics A Grant For Up To $25 Million To Develop Messenger RNA Therapeutics™

October 2, 2013
Not Flagship

BG Medicine Announces Preliminary Decision by CMS on Reconsideration of Reimbursement for BGM Galectin-3 Test

September 30, 2013
Not Flagship

Agios Pharmaceuticals Appoints Paul J. Clancy to Its Board of Directors

September 26, 2013
Not Flagship

Moderna Therapeutics Named a "Fierce 15" Biotech Company for 2013

September 24, 2013
Not Flagship

Visterra Named One of the “Fierce 15” Leading Biotech Companies of 2013

September 24, 2013
Not Flagship

Novomer Catalytic Process Using Waste CO2 and Shale Gas Targets $20 Billion Market and up to 110% Carbon Footprint Reduction

September 24, 2013
Not Flagship

Agios Pharmaceuticals Enrolls First Patient in Phase 1 Study of AG-221 in Advanced Hematologic Malignancies with an IDH2 Mutation

September 23, 2013
Not Flagship

BG Medicine, Inc. Welcomes Galectin-3 Clinical Research Data From the PROTECT Study Conducted at Massachusetts General Hospital Demonstrating Predictive Value of Adverse Outcomes in Heart Failure Patients

September 23, 2013
Not Flagship

Eleven Biotherapeutics Presents Positive Clinical Data on EBI‐005, a Targeted Protein Therapeutic for

September 20, 2013
Not Flagship

BIND Therapeutics Announces Pricing of Initial Public Offering

September 19, 2013
Not Flagship

Acceleron Announces Pricing of Initial Public Offering

September 18, 2013
Not Flagship

Tangent Medical Wins Gold & Silver Stevie® Awards

September 18, 2013
Not Flagship

Quanterix Launches Multiplexed Single Molecule Immunoassay Technology to Improve Diagnosis and Potential Treatment of Complex Diseases

September 17, 2013
Not Flagship

Visterra Announces an Oral Presentation of VIS410 Data that Showed Neutralization of H5 and H7 Influenza Strains with Pandemic Potential

September 12, 2013
Not Flagship

Visterra Presents Prophylactic and Therapeutic Efficacy Data of VIS410 Against Multiple Influenza Strains with Pandemic Potential

September 9, 2013
Not Flagship

T2 Biosystems Announces direcT2 Pivotal Clinical Trial of T2Candida Enrolling at All Clinical Sites

September 9, 2013
Not Flagship

Study Published in Nature Biotechnology Demonstrates Ability of Moderna's Novel Therapeutic Paradigm to Repair and Regenerate Damaged Heart Tissue

September 8, 2013
Not Flagship

Syros Pharmaceuticals Appoints Vicki L. Sato, Ph.D., to Board of Directors

September 5, 2013
Not Flagship

Affinnova Reveals Bottle Design Trumps Taste in Vodka Brand War

September 4, 2013
Not Flagship

Flagship VentureLabs Launches Midori Renewables

September 4, 2013
Not Flagship

Tetraphase Doses First Patient in Phase 3 Clinical Trial of Eravacycline in Complicated Intra-abdominal Infections

September 3, 2013
Not Flagship

The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014

August 28, 2013
Is Flagship Story

36 Innovative Companies Recognized as World Economic Forum Technology Pioneers

August 27, 2013
Not Flagship

Seahorse Bioscience and the Cancer Research UK Beatson Institute Team Up Against Cancer

August 22, 2013
Not Flagship

BIND Doses First Patient in a Phase 2 Clinical Study of BIND-014 in Prostate Cancer

August 19, 2013
Not Flagship

Joule Announces Leadership Changes

August 19, 2013
Not Flagship

Paul Meister Joins Quanterix Board of Directors

August 15, 2013
Not Flagship

Receptos Announces Issuance of Composition of Matter Patents Covering Proprietary Lead Product Candidate RPC1063

August 13, 2013
Not Flagship

BIND Therapeutics Files Registration Statement for Proposed Initial Public Offering

August 12, 2013
Not Flagship

Tetraphase Pharmaceuticals Inc.: Tetraphase Reports Second Quarter 2013 Financial Results

August 12, 2013
Not Flagship

BG Medicine Reports 2013 Second Quarter Financial Results and Provides Second Half Outlook

August 8, 2013
Not Flagship

Acceleron Files Registration Statement for Proposed Initial Public Offering

August 7, 2013
Not Flagship

Receptos Reports Second Quarter 2013 Financial Results

August 7, 2013
Not Flagship

Ensemble Therapeutics Forms Global Strategic Collaboration for Development of Oral, Macrocyclic IL-17 Antagonists and Additional Disease Targets

August 6, 2013
Not Flagship

PharmaVOICE Magazine Announces the 2013 PharmaVOICE 100

August 1, 2013
Is Flagship Story

Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development

July 31, 2013
Not Flagship

Quanterix Announces Commercial Availability of its Simoa Single Molecule Array Technology

July 30, 2013
Not Flagship

BIND Doses First Patient in a Phase 2 Clinical Study of BIND-014 in Non-Small Cell Lung Cancer

July 29, 2013
Not Flagship

Agios Pharmaceuticals Prices Initial Public Offering

July 23, 2013
Not Flagship

Receptos Announces Appointment of Erle T. Mast as Director

July 22, 2013
Not Flagship

Ensemble Therapeutics and Alexion Initiate Collaboration to Discover Macrocycle Drug Candidates Targeting Patients with Severe and Ultra-Rare Disorders

July 18, 2013
Not Flagship

Visterra Appoints Brian Pereira, M.D., as President and Chief Executive Officer

July 15, 2013
Not Flagship

FDA Grants QIDP Designation to Eravacycline, Tetraphase’s Lead Antibiotic Product Candidate

July 15, 2013
Not Flagship

T2 Biosystems Announces New Data Correlating T2HemoStat(TM) Results to Clinical Outcomes in Cardiovascular Disease at ISTH

July 1, 2013
Not Flagship

Black Duck Taps Protobrand Chairman and Founder Phil Granof as CMO

July 1, 2013
Not Flagship

Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer

June 28, 2013
Not Flagship

Eleven Biotherapeutics Announces Positive Topline Data on EBI-005, a Novel Topical IL-1 Inhibitor Protein Therapeutic, in Patients with Dry Eye Disease

June 28, 2013
Not Flagship

Tangent Medical Announces U.S. Launch of the NovaCath™ Integrated IV Catheter System

June 27, 2013
Not Flagship

Constructing Innovation Supply Chains for the Pharmaceutical Industry

June 26, 2013
Is Flagship Story

Affinnova Named to Honomichl Top 50 List for Third Consecutive Year

June 24, 2013
Not Flagship

Flagship Ventures Kicks-off its VentureLabs™ Entrepreneurial Fellowship Program

June 20, 2013
Is Flagship Story

Mascoma Announces FDA Favorable Review of its Next Generation Bioengineered Yeast, TransFerm® Yield+

June 18, 2013
Not Flagship

Affinnova Launches Expansion to Asia

June 17, 2013
Not Flagship

BG Medicine Welcomes Inclusion of Galectin-3 as Biomarker of Myocardial Fibrosis in 2013 ACCF/AHA Guideline for Management of Heart Failure

June 12, 2013
Not Flagship

Tangent Medical Showcases the NovaCath(TM) Integrated IV Catheter System at National Event Committed to Healthcare Innovation

June 12, 2013
Not Flagship

Agios Pharmaceuticals files for IPO of up to $86 million

June 11, 2013
Not Flagship

Concert Pharmaceuticals Initiates Phase 1 Clinical Trial of CTP-354, a Potential Treatment for Spasticity and Pain

June 10, 2013
Not Flagship

Lallemand Biofuels & Distilled Spirits and Mascoma Announce Introduction of Next Generation Bioengineered Yeast

June 10, 2013
Not Flagship

T2 Biosystems Appoints Marc Jones and Frédéric Sweeney, Ph.D., to Senior Management Team

June 6, 2013
Not Flagship

Receptos Provides Update on Progress of Lead Product Candidate RPC1063

June 5, 2013
Not Flagship

Acceleron Named to the "Best Places to Work" List by The Scientist Magazine

June 4, 2013
Not Flagship

BG Medicine Announces Late-Breaker Oral Presentation of New Data on the BGM Galectin-3(R) Test in Heart Failure

May 28, 2013
Not Flagship

Eleven Biotherapeutics Announces Collaboration with ThromboGenics to Develop a Novel Protein Therapeutic for Ophthalmic Disease

May 28, 2013
Not Flagship

Life Science Industry Veteran Stéphane Bancel Joins Flagship Ventures

May 22, 2013
Is Flagship Story

Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer

May 22, 2013
Not Flagship

Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer

May 22, 2013
Not Flagship

Frost & Sullivan Recognizes Selventa's Proprietary Systems Diagnostics Technology Platform

May 13, 2013
Not Flagship

Tetraphase Reports First Quarter 2013 Financial Results

May 13, 2013
Not Flagship

Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes

May 10, 2013
Not Flagship

Affinnova Wins SBANE Innovation Award

May 10, 2013
Not Flagship

BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer

May 9, 2013
Not Flagship

BG Medicine Reports 2013 First Quarter Financial Results

May 9, 2013
Not Flagship

T2 Biosystems Named 2013 SBANE New England Innovation Award Winner

May 9, 2013
Not Flagship

Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, to Reduce Hospital Readmissions

May 8, 2013
Not Flagship

Selventa Strengthens Intellectual Property for System Diagnostics (SysDx™) Approach to Personalized Medicine

May 8, 2013
Not Flagship

Eleven Biotherapeutics Presents Data on EBI-005, a Novel IL-1 Inhibitor Protein Therapeutic for Topical Treatment of Dry Eye Disease

May 8, 2013
Not Flagship

Receptos Announces Pricing of Initial Public Offering of Common Stock

May 8, 2013
Not Flagship

Concert Pharmaceuticals Announces Strategic Collaboration with Celgene Corporation to Develop Deuterium-Modified Compounds

May 6, 2013
Not Flagship

Henri A. Termeer Joins Moderna Therapeutics Board of Directors

April 30, 2013
Not Flagship

Tetraphase Presents Data at ECCMID Supporting Efficacy of Two Antibiotic Candidates Against Multi-Drug Resistant Infections

April 29, 2013
Not Flagship

Transmedics® Announces Interim Results From the International Inspire Pivotal Trial Using the OCS™ Lung System

April 25, 2013
Not Flagship

T2 Bio publishes data supporting diagnostic test T2Candida® in Science Translational Medicine

April 24, 2013
Not Flagship

Seegene and Selventa Form Strategic Collaboration to Develop Novel Molecular Diagnostics (MoDx)

April 23, 2013
Not Flagship

Joule Named 2013 New Energy Pioneer By Bloomberg

April 23, 2013
Not Flagship

Bind Therapeutics and AstraZeneca Announce Worldwide Development and Commercialization Agreement For Cancer Nanomedicine

April 22, 2013
Not Flagship

LS9 Expands Operations at Its Florida Demonstration Facility With Successful Customer Trial

April 17, 2013
Not Flagship